The acid sphingomyelinase deficiency (ASMD) market is estimated to be valued at USD 134.6 Mn in 2024 and is expected to reach USD 300 Mn by 2031, growing at a compound annual growth rate (CAGR) of 12.1% from 2024 to 2031. https://www.zupyak.com/p/4489576/t/acid-sphingomyelinase-deficiency-asmd-market-will-witness-high-growth-due-to-rising-disease-awareness-and-diagnosis